News
Filters
Showing 1 - 6 out of 6 results
News
Strokes During Commute Turned MoBap Provider Into Grateful Patient
Article
Witnessing a breakthrough: physicians find hope in new Alzheimer’s drug
For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.
But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.
Article
Five Overlooked Screenings You Should Include on Your Preventive Care Checklist
Patient Story
Restoring Hope: How a Breakthrough Treatment Helped a Teenager Defeat Epilepsy
Article
What is a Medicare Annual Wellness Visit?
Article